1-12002033-C-T
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_014874.4(MFN2):c.1090C>T(p.Arg364Trp) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R364L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_014874.4 missense
Scores
Clinical Significance
Conservation
Publications
- neuropathy, hereditary motor and sensory, type 6AInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b;Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- axonal hereditary motor and sensory neuropathyInheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
- Charcot-Marie-Tooth disease type 2A2Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- hereditary motor and sensory neuropathy type 6Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- multiple symmetric lipomatosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- severe early-onset axonal neuropathy due to MFN2 deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MFN2 | NM_014874.4 | c.1090C>T | p.Arg364Trp | missense_variant | Exon 11 of 19 | ENST00000235329.10 | NP_055689.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MFN2 | ENST00000235329.10 | c.1090C>T | p.Arg364Trp | missense_variant | Exon 11 of 19 | 1 | NM_014874.4 | ENSP00000235329.5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2A2 Pathogenic:8
- -
- -
- -
- -
- -
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Missense variant Functional studies provide moderate evidence of the variant having a damaging effect on the gene or gene product (PMID: 29898954). In silico tool predictions suggest damaging effect of the variant on gene or gene product [REVEL: 0.86 (>=0.6, sensitivity 0.68 and specificity 0.92); 3Cnet: 0.96 (>=0.6, sensitivity 0.72 and precision 0.9)]. Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000002278 /PMID: 16437557 /3billion dataset). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 22206013, 22762946, 25448007, 28063088). Different missense changes at the same codon (p.Arg364Gln, p.Arg364Leu, p.Arg364Pro) have been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000245944, VCV000572157, VCV000801445 /PMID: 17444508, 20008656 /3billion dataset). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
Analysis of variants by whole exome sequencing in previously established disease genes identified a heterozygous variant in exon 11 of the MFN2 gene (p.Arg364Trp, ClinVar VCV000002278.36) which is an established pathogenic variant for autosomal dominant Charcot-Marie-Tooth disease type 2A2 (MONDO:0012231). Sequencing funded by the International Centre for Genomic Medicine in Neuromuscular Diseases (ICGNMD): https://www.ucl.ac.uk/genomic-medicine-neuromuscular-diseases/. -
The MFN2 c.1090C>T variant is classified as PATHOGENIC (PS2, PS4, PP3) The MFN2 c.1090C>T variant is a single nucleotide change in exon 11/19 of the MFN2 gene, which is predicted to change the amino acid arginine at position 364 in the protein to tryptophan. This variant is de novo in this patient (PS2). This variant has been reported in multiple individuals with Charcot-Marie-Tooth disease type 2 (PMID:24819634, PMID:21508331, PMID:28063088) (PS4). this variant has not been reported in dbSNP and is absent from population databases. This variant has been reported in ClinVar as pathogenic for Charcot-Marie-Tooth disease (ClinVar Variation ID: 2278). Other variants affecting this amino acid residue have also been reported as pathogenic suggesting this residue is clinically significant. Computational predictions support a deleterious effect on the gene or gene product (PP3). -
not provided Pathogenic:3
This variant has not been reported in large, multi-ethnic general populations. (http://gnomad.broadinstitute.org) This variant has been identified in multiple unrelated individuals with autosomal dominant Charcot-Marie-Tooth disease, including multiple de novo cases, and appears to segregate with disease in at least one family. Assessment of experimental evidence regarding the effect of this variant on protein function is inconclusive (PMID: 25448007, 29898954). At least one other missense variant at this codon is considered to be pathogenic or likely pathogenic, suggesting this variant may also cause disease. -
- -
Reported multiple times in association with hereditary motor and sensory neuropathy type VI and CMT2A in published literature (Zuchner et al., 2006; Chung et al., 2006; Gowrisankaran et al., 2011); Published functional studies demonstrate a damaging effect (Saporta et al., 2015); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 24819634, 16835246, 21707411, 31832804, 21508331, 31211173, 16437557, 22206013, 27549087, 30996168, 30649465, 20587496, 25802885, 22492563, 31673878, 31315766, 33578441, 30569560, 33074106, 33742459, 30830587, 25448007, 28063088, 24863639) -
Charcot-Marie-Tooth disease type 2 Pathogenic:2
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 364 of the MFN2 protein (p.Arg364Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with Charcot-Marie-Tooth disease type 2A and hereditary motor and sensory neuropathy type VI (PMID: 16437557, 16835246, 21508331, 21707411, 22206013, 22492563, 25448007, 25802885, 27549087, 28063088). ClinVar contains an entry for this variant (Variation ID: 2278). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MFN2 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg364 amino acid residue in MFN2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17444508, 18996695, 20008656, 21508331, 22492563). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
Hereditary motor and sensory neuropathy with optic atrophy Pathogenic:2
- -
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported as disease causing [PMID 16437557, 21707411, 27549087, 25448007, 28063088] -
Charcot-Marie-Tooth disease Uncertain:1
- -
Charcot-Marie-Tooth disease type 4 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at